NCT00355108View on ClinicalTrials.gov

ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Telangiectasia, Hereditary HemorrhagicOsler-Rendu Disease
Interventions
DRUG

tranexamic acid

2 3-month-periods in cross-over: placebo or 3g/day of tranexamic acid

Trial Locations (1)

69002

Henri PLAUCHU, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT00355108 - ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome | Biotech Hunter | Biotech Hunter